Skip to main content
Premium Trial:

Request an Annual Quote

Montreal Heart Institute Named Roche Global Cardiometabolic Research Hub

NEW YORK (GenomeWeb News) – The Montreal Heart Institute today was designated by Roche as a global research hub for cardiometabolic research.

The partnership between Roche and the institute will focus on furthering basic scientific research into personalized healthcare for patients, they said.

"This alliance will provide a unique opportunity to drive translational and personalized medicine from molecular discovery up to testing new drugs in the area of cardiovascular and metabolic diseases," Jean-Claude Tardif, director of the MHI Research Center and Canada Research Chair in personalized and translational medicine, said in a statement.

David Kallend, Roche global clinical leader and pharma development group medical director, added that the institute's "focused research into new biomarkers to predict cardiovascular diseases and stratification of high-risk patients make MHI the ideal partner for Roche in cardiovascular research."

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.